Please enable JavaScript to continue using this application.

Compare $ALXO vs $NKTX | Chartloom

Compare

$ALXO vs $NKTX

ALX Oncology Holdings Inc · Nkarta Inc

ALXO

ALX Oncology Holdings Inc

NKTX

Nkarta Inc

Compare $ALXO vs $NKTX

Comparing ALX Oncology Holdings Inc and Nkarta Inc

ALXOALX Oncology Holdings Inc

NKTXNkarta Inc

ALXOALX Oncology Holdings Inc

Market cap

$168M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

8.7%

52W performance

-36.5%

FCF yield

-42.2%

NKTXNkarta Inc

Market cap

$161M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

20.3%

52W performance

7.7%

FCF yield

-58.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ALXO

NKTX

Detailed metrics comparison

ALXO

ALX Oncology Holdings Inc

NKTX

Nkarta Inc

Market Cap

ALXO$168M

NKTX$161M

Enterprise Value

ALXO$156M

NKTX$136M

Price

ALXO$1.25

NKTX$2.25

P/E Ratio

ALXON/A

NKTXN/A

P/S Ratio

ALXO46.09x

NKTX0.00x

EV/Sales

ALXO0.00x

NKTX0.00x

EV/EBITDA

ALXO0.00x

NKTX0.00x

P/B Ratio

ALXO1.24x

NKTX0.74x

P/FCF Ratio

ALXON/A

NKTXN/A

EV/FCF

ALXO-2.20x

NKTX-1.45x

PEG Ratio

ALXON/A

NKTXN/A

Forward P/E (NTM)

ALXON/A

NKTXN/A

Forward P/S (NTM)

ALXON/A

NKTXN/A

Revenue (TTM)

ALXO$0

NKTX$0

Revenue Growth (YoY)

ALXON/A

NKTXN/A

Forward Rev Growth

ALXO357.6%

NKTX2561.2%

Gross Margin (TTM)

ALXO9.0%

NKTX0.0%

Operating Margin (TTM)

ALXO0.0%

NKTX0.0%

EBITDA Margin (TTM)

ALXO0.0%

NKTX0.0%

Net Margin (TTM)

ALXO0.0%

NKTX0.0%

FCF Margin (TTM)

ALXON/A

NKTXN/A

Net Income (TTM)

ALXO$-81M

NKTX$-117M

FCF (TTM)

ALXO$-71M

NKTX$-94M

EPS (TTM)

ALXO-$0.60

NKTX-$1.57

ROE (TTM)

ALXO-9030.0%

NKTX-3964.0%

ROA (TTM)

ALXO-6728.0%

NKTX-3045.0%

ROIC (TTM)

ALXO-8046.0%

NKTX-3964.0%

Cash

ALXO$23M

NKTX$25M

Debt

ALXO$11M

NKTX$0

Net Cash/Debt

ALXO$12M

NKTX$25M

Current Ratio (TTM)

ALXO9.71x

NKTX7.98x

Quick Ratio (TTM)

ALXO9.44x

NKTX7.76x

Debt/Equity (TTM)

ALXO0.08x

NKTX0.00x

Debt/Assets (TTM)

ALXO0.0%

NKTX0.0%

Interest Coverage (TTM)

ALXON/A

NKTXN/A

Net Debt/EBITDA (TTM)

ALXO0.00x

NKTX0.00x

Beta

ALXO0.55

NKTX1.19

52W Performance

ALXO-36.5%

NKTX7.7%

YTD Performance

ALXO8.7%

NKTX20.3%

% from 52W High

ALXO-53.0%

NKTX-39.5%

% from 52W Low

ALXO19.0%

NKTX32.4%

Asset Turnover (TTM)

ALXO0.00x

NKTX0.00x

FCF Yield (TTM)

ALXO-42.2%

NKTX-58.3%

Earnings Yield (TTM)

ALXO-48.1%

NKTX-72.9%

Dividend Yield (TTM)

ALXON/A

NKTXN/A

Rule of 40

ALXO0.0

NKTX0.0

EV/GP/RG

ALXON/A

NKTXN/A

Ticker research

View ALXO research View NKTX research

Metric	ALXO ALX Oncology Holdings Inc	NKTX Nkarta Inc
Market & Valuation
Market Cap	$168M	$161M
Enterprise Value	$156M	$136M
Price	$1.25	$2.25
P/E Ratio	N/A	N/A
P/S Ratio	46.09x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.24x	0.74x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.20x	-1.45x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	357.6%	2561.2%
Profitability
Gross Margin (TTM)	9.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-81M	$-117M
FCF (TTM)	$-71M	$-94M
EPS (TTM)	-$0.60	-$1.57
ROE (TTM)	-9030.0%	-3964.0%
ROA (TTM)	-6728.0%	-3045.0%
ROIC (TTM)	-8046.0%	-3964.0%
Financial Health
Cash	$23M	$25M
Debt	$11M	$0
Net Cash/Debt	$12M	$25M
Current Ratio (TTM)	9.71x	7.98x
Quick Ratio (TTM)	9.44x	7.76x
Debt/Equity (TTM)	0.08x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.55	1.19
52W Performance	-36.5%	7.7%
YTD Performance	8.7%	20.3%
% from 52W High	-53.0%	-39.5%
% from 52W Low	19.0%	32.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-42.2%	-58.3%
Earnings Yield (TTM)	-48.1%	-72.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ALXO research	View NKTX research

Valuation

P/S Ratio

NKTX

0.00x

ALXO

46.09x

EV/FCF

ALXO

-2.20x

NKTX

-1.45x

Growth & revenue

Forward Revenue Growth

NKTX

2561.2%

ALXO

357.6%

Profitability & performance

Gross Margin

ALXO

9.0%

NKTX

0.0%

ROE

NKTX

-3964.0%

ALXO

-9030.0%

FCF Yield %

ALXO

-42.2%

NKTX

-58.3%

52-Week Performance

NKTX

7.7%

ALXO

-36.5%

Detailed metrics comparison

ALXO

ALX Oncology Holdings Inc

NKTX

Nkarta Inc

Market Cap

ALXO$168M

NKTX$161M

Enterprise Value

ALXO$156M

NKTX$136M

Price

ALXO$1.25

NKTX$2.25

P/E Ratio

ALXON/A

NKTXN/A

P/S Ratio

ALXO46.09x

NKTX0.00x

EV/Sales

ALXO0.00x

NKTX0.00x

EV/EBITDA

ALXO0.00x

NKTX0.00x

P/B Ratio

ALXO1.24x

NKTX0.74x

P/FCF Ratio

ALXON/A

NKTXN/A

EV/FCF

ALXO-2.20x

NKTX-1.45x

PEG Ratio

ALXON/A

NKTXN/A

Forward P/E (NTM)

ALXON/A

NKTXN/A

Forward P/S (NTM)

ALXON/A

NKTXN/A

Revenue (TTM)

ALXO$0

NKTX$0

Revenue Growth (YoY)

ALXON/A

NKTXN/A

Forward Rev Growth

ALXO357.6%

NKTX2561.2%

Gross Margin (TTM)

ALXO9.0%

NKTX0.0%

Operating Margin (TTM)

ALXO0.0%

NKTX0.0%

EBITDA Margin (TTM)

ALXO0.0%

NKTX0.0%

Net Margin (TTM)

ALXO0.0%

NKTX0.0%

FCF Margin (TTM)

ALXON/A

NKTXN/A

Net Income (TTM)

ALXO$-81M

NKTX$-117M

FCF (TTM)

ALXO$-71M

NKTX$-94M

EPS (TTM)

ALXO-$0.60

NKTX-$1.57

ROE (TTM)

ALXO-9030.0%

NKTX-3964.0%

ROA (TTM)

ALXO-6728.0%

NKTX-3045.0%

ROIC (TTM)

ALXO-8046.0%

NKTX-3964.0%

Cash

ALXO$23M

NKTX$25M

Debt

ALXO$11M

NKTX$0

Net Cash/Debt

ALXO$12M

NKTX$25M

Current Ratio (TTM)

ALXO9.71x

NKTX7.98x

Quick Ratio (TTM)

ALXO9.44x

NKTX7.76x

Debt/Equity (TTM)

ALXO0.08x

NKTX0.00x

Debt/Assets (TTM)

ALXO0.0%

NKTX0.0%

Interest Coverage (TTM)

ALXON/A

NKTXN/A

Net Debt/EBITDA (TTM)

ALXO0.00x

NKTX0.00x

Beta

ALXO0.55

NKTX1.19

52W Performance

ALXO-36.5%

NKTX7.7%

YTD Performance

ALXO8.7%

NKTX20.3%

% from 52W High

ALXO-53.0%

NKTX-39.5%

% from 52W Low

ALXO19.0%

NKTX32.4%

Asset Turnover (TTM)

ALXO0.00x

NKTX0.00x

FCF Yield (TTM)

ALXO-42.2%

NKTX-58.3%

Earnings Yield (TTM)

ALXO-48.1%

NKTX-72.9%

Dividend Yield (TTM)

ALXON/A

NKTXN/A

Rule of 40

ALXO0.0

NKTX0.0

EV/GP/RG

ALXON/A

NKTXN/A

Ticker research

View ALXO research View NKTX research

Metric	ALXO ALX Oncology Holdings Inc	NKTX Nkarta Inc
Market & Valuation
Market Cap	$168M	$161M
Enterprise Value	$156M	$136M
Price	$1.25	$2.25
P/E Ratio	N/A	N/A
P/S Ratio	46.09x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.24x	0.74x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.20x	-1.45x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	357.6%	2561.2%
Profitability
Gross Margin (TTM)	9.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-81M	$-117M
FCF (TTM)	$-71M	$-94M
EPS (TTM)	-$0.60	-$1.57
ROE (TTM)	-9030.0%	-3964.0%
ROA (TTM)	-6728.0%	-3045.0%
ROIC (TTM)	-8046.0%	-3964.0%
Financial Health
Cash	$23M	$25M
Debt	$11M	$0
Net Cash/Debt	$12M	$25M
Current Ratio (TTM)	9.71x	7.98x
Quick Ratio (TTM)	9.44x	7.76x
Debt/Equity (TTM)	0.08x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.55	1.19
52W Performance	-36.5%	7.7%
YTD Performance	8.7%	20.3%
% from 52W High	-53.0%	-39.5%
% from 52W Low	19.0%	32.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-42.2%	-58.3%
Earnings Yield (TTM)	-48.1%	-72.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ALXO research	View NKTX research